Patents
Vactech is the sole owner of the patents and patent applications covering the preventive Type 1 Diabetes vaccine. In addition, Vactech’s patents cover antiviral drugs and diagnostic assays for Type 1 Diabetes enabling the company to build a product family around diabetes prevention and cure. The IPR portfolio includes in addition international patents covering virus-based products to treat and prevent Allergies, Asthma and Celiac Disease.
Please, find attached and download Vactech patents and patent applications and a description how this IPR is related to our projects and products.
| Project | Description | IPR |
|---|---|---|
|
Type 1 Diabetes, T1D |
Preventive enterovirus vaccine Indication: Prevention of T1D and enterovirus infections |
Background patent granted in USA, EPO Multivalent CBV vaccine patent granted in EPO, USA |
|
Other preventive and therapeutic antiviral agents (drugs, antibodies) Indication: Treatment of individuals who have subclinical or clinical T1D, prevention of T1D |
||
|
Diagnostic tests for diabetogenic enteroviruses Indication: Identification of individuals infected by a diabetogenic virus and treatable by antiviral agents, monitoring the efficacy of antiviral treatments |
Patent granted in EPO |
| Project | Description | IPR |
|---|---|---|
|
Celiac Disease, CD |
Preventive enterovirus vaccine Indication: Prevention of CD and enterovirus infections |
Patent granted in EPO |
|
Other preventive and therapeutic antiviral agents (drugs, antibodies) Indication: Treatment of individuals who have subclinical clinical CD, prevention of T1D |
||
|
Diagnostic tests for identification of individuals infected by an enterovirus Indication: Identification of individuals infected by a CD associated virus and treatable by antiviral agents, monitoring the efficacy of antiviral treatments |
| Project | Description | IPR |
|---|---|---|
|
Allergic Diseases and Asthma |
Entero/rhinovirus vaccines and antivirals Indication: Prevention of allergic diseases and asthma |
Patent granted in USA, EPO, Russia, Australia, New Zeeland, South Africa |
|
Entero/rhinovirus based immunomodulators Indication: Prevention and treatment of allergic diseases and asthma |
| Project | Description | IPR |
|---|---|---|
|
Technologies |
Inactivated enterovirus vaccines Virus Like Particles, VLP (IMAVAC ™) |
Included in patents and patent applications |